Patent Number: 6,255,308

Title: Treatment of equine protozoal myeloencephalitis

Abstract: The present invention relates to compositions and methods for treating equines, such as horses, afflicted with equine protozoal myeloencephalitis or EPM. The therapeutic compositions comprise a combination of pyrimethamine and a sulfonamide, preferably, sulfadiazine, in the absence of known therapeutic amounts of trimethoprim.

Inventors: Russell; Meri Charm (Des Moines, IA), Fenger; Clara K. (Lexington, KY)

Assignee: Blue Ridge Pharmaceuticals, Inc.

International Classification: A61K 31/63 (20060101); A61K 031/505 (); A61K 031/18 ()

Expiration Date: 07/03/2018